20/20 Biolabs, Inc. (AIDX): Form 8-K filed 2026-07-22
- Accepted by EDGAR
- 2026-07-22 16:45 ET
- Event date
- 2026-07-16
- Accession no.
- 0001213900-26-080432
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements. - Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The company received notice from its exchange that it does not satisfy a continued listing rule (for example a minimum bid price or filing requirement), or it decided to delist or transfer its listing. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0298907-8k_2020bio.htm |
| EX-10.1 | STANDSTILL AGREEMENT, DATED JULY 16, 2026, BETWEEN STREETERVILLE CAPITAL, LLC AN | ea029890701ex10-1.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.